Core Laboratories N.V. (CLB)
Market Cap | 1.16B |
Revenue (ttm) | 487.30M |
Net Income (ttm) | 15.39M |
Shares Out | 46.37M |
EPS (ttm) | 0.33 |
PE Ratio | 75.97 |
Forward PE | 19.08 |
Dividend | $0.04 (0.16%) |
Ex-Dividend Date | Nov 4, 2022 |
Volume | 317,158 |
Open | 24.32 |
Previous Close | 24.45 |
Day's Range | 24.32 - 25.29 |
52-Week Range | 13.19 - 35.83 |
Beta | 2.61 |
Analysts | Hold |
Price Target | 22.61 (-9.81%) |
Earnings Date | Feb 1, 2023 |
About CLB
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize pr... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for CLB stock is "Hold." The 12-month stock price forecast is $22.61, which is a decrease of -9.81% from the latest price.
News

Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Core Labs (CLB) Reveals Plans to Transfer Domicile to U.S.
Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing ...

CORE LAB ANNOUNCES PROPOSED REDOMESTICATION TO THE UNITED STATES
AMSTERDAM , Jan. 17, 2023 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US") ("Core", "Core Lab", or the "Company") announces the Company's Board of Directors has approved a plan to reorganize th...

CORE LABORATORIES' FOURTH QUARTER 2022 WEBCAST AT 7:30 A.M. CST / 2:30 P.M.
AMSTERDAM , Jan. 4, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2022 conference call over the Internet at 7:30 a.m. CST /...

SLB or CLB: Which Is the Better Value Stock Right Now?
SLB vs. CLB: Which Stock Is the Better Value Option?

Core Laboratories (CLB) Up 9.6% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

SLB vs. CLB: Which Stock Is the Better Value Option?
SLB vs. CLB: Which Stock Is the Better Value Option?

Core Labs (CLB) Q3 Earnings Surpass Estimates, Sales Meet
Core Labs' (CLB) third-quarter earnings beat the consensus mark, while revenues meet the same.

CORE LAB REPORTS THIRD QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS:
THIRD QUARTER REVENUE OF $126 MILLION; UP 4% SEQUENTIALLY; UP 7% YEAR-OVER-YEAR THIRD QUARTER OPERATING INCOME UP OVER 25% SEQUENTIALLY AND, EX-ITEMS, UP OVER 38% SEQUENTIALLY THIRD QUARTER SEQUENTIAL...

Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CORE LABORATORIES' THIRD QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M.
AMSTERDAM , Sept. 27, 2022 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its third quarter 2022 conference call over the Internet at 7:30 a.m.

SLB vs. CLB: Which Stock Should Value Investors Buy Now?
SLB vs. CLB: Which Stock Is the Better Value Option?

Core Labs (CLB) Q2 Earnings Meet Estimates, Sales Narrowly Beat
Core Laboratories' (CLB) second-quarter earnings meet the consensus mark, while revenues marginally outperform the same.

Core Laboratories (CLB) Q2 Earnings Match Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CORE LAB REPORTS SECOND QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS
SECOND QUARTER REVENUE OF $120.9 MILLION; UP 5% SEQUENTIALLY; UP 2% YEAR-OVER-YEAR SECOND QUARTER SEQUENTIAL INCREMENTAL MARGINS, EX-ITEMS, 43%, DRIVEN BY RESERVOIR DESCRIPTION SECOND QUARTER GAAP EPS...

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Madison Core Laboratories Welcomes New Chief Financial Officer
HUNTSVILLE, Ala.--(BUSINESS WIRE)-- #diagnostics--Madison Core Laboratories, LLC (MCL) announces the appointment of Jerry C. Smith, a seasoned financial executive, as Chief Financial Officer (“CFO”). ...

CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M.
AMSTERDAM , June 28, 2022 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2022 conference call over the Internet at 7:30 a.m. CDT ...

CORE LAB ANNOUNCES $60,000,000 AT-THE-MARKET EQUITY OFFERING PROGRAM
AMSTERDAM , June 9, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core," "Core Lab," or the "Company") announced today that it has established an at-t...

Core Laboratories (CLB) Up 2.6% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat
Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.

Core Laboratories (CLB) Tops Q1 Earnings and Revenue Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of 33.33% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CORE LAB REPORTS FIRST QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS
FIRST QUARTER REVENUE OF $115.3 MILLION; UP 6% YEAR-OVER-YEAR FIRST QUARTER GAAP EPS OF $(0.04); EPS, EX-ITEMS, $0.08 LAUNCH OF INDUSTRY CARBON CAPTURE AND SEQUESTRATION ("CCS") CONSORTIUM CCS STRATEG...

Is a Surprise Coming for Core Laboratories (CLB) This Earnings Season?
Core Laboratories (CLB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.